High affinity binding of monoclonal antibodies to the sequential epitope EFRH of β-amyloid peptide is essential for modulation of fibrillar aggregation

Journal of Neuroimmunology

Volumn 95, Issue 1-2, 1999, Pages 136-142

  Frenkel, D ^a   Balass, M ^b   Katchalski Katzir, E ^b   Solomon, B ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Amyloid modulation; Antibodies affinity; EFRH epitope

Indexed keywords

AMYLOID BETA PROTEIN; EPITOPE; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANTIBODY AFFINITY; ARTICLE; BINDING AFFINITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; THROMBOCYTE AGGREGATION;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIBODIES, MONOCLONAL; BACTERIOPHAGES; BINDING, COMPETITIVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; GENE LIBRARY; HUMANS; MOLECULAR SEQUENCE DATA; NEUROFIBRILLARY TANGLES;

EID: 0033103657     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00003-X     Document Type: Article

References (31)

1. Ashall F., Goate A.M. Role of the β-amyloid precursor protein in Alzheimer disease. Trends Biochem. Sci. 19:1994;42-46.
2. Balass M., Heldman Y., Cabilly S., Givol D., Katchalski-Katzir E., Fuchs S. Identification of a hexapeptide that mimics a conformation-dependent binding site of acetylcholine receptor by use of a phage-epitope library. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10638-10642.
3. Blond S., Goldberg M. Partly native epitopes are already present on early intermediates in the folding of tryptophan synthase. Prof. Natl. Acad. Sci. U.S.A. 84:1987;1147.
4. Cruz L., Urbanc B., Buldyrev S.V., Christie R., Gomez-Isla T., Havlin S., McNamara M., Stanley H.E., Hyman B.T. Aggregation and disaggregation of senile plaques in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7612-7616.
5. Dalal S., Balasubramanian S., Regan L. Protein alchemy: changing β-sheet into α-helix. Nature Struc. Biol. 4:1997;548-552.
6. Devlin J.J., Panganiban L.C., Devlin P.E. Random peptide libraries: a source of specific protein binding molecules. Science. 249:1990;404-406.
7. Frenkel D., Balass M., Solomon B. N-Terminal EFRH sequence of Alzheimer's β-amyloid peptide represents the epitope of its anti-aggregation antibodies. J. Neuroimmunol. 88:1998;85-90.
8. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C.et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523.
9. Hanan-Aharon E., Solomon B. Inhibitory effect of monoclonal antibodies on Alzheimer's β-amyloid peptide aggregation. Amyloid: Int. J. Exp. Clin. Invest. 3:1996;130-133.
10. Howlett D.R., Jennings K.H., Lee D.C., Clark M.S.G., Brown F., Wetzel R., Wood S.J., Camilleri P., Roberts G.W. Aggregation state and neurotoxic properties of Alzheimer Beta-amyloid peptide. Neurodegeneration. 4:1995;23-32.
11. Hyman B.T., Tanzi R.B., Marxloff K., Barbour R., Schenk D.B. Kunitz protease inhibitor-containing amyloid β-protein precursor immunoreactivity in Alzheimer's disease. J. Neuropath. Exp. Neurol. 51:1992;76.
12. Katzav-Gozansky T., Hanan E., Solomon B. Effect of monoclonal antibodies in preventing carboxypeptidase A aggregation. Biotechnol. Appl. Biochem. 23:1996;227.
13. Katzman R. Alzheimer's disease. N. Engl. J. Med. 314:1986;964-973.
14. Kirshenbaum K., Daggett V. Sequence effects on the conformational properties of the amyloid β (1-28) peptide: testing a proposed mechanism for the α→β transition. Biochemistry. 34:1995;7640-7647.
15. Lee J.P., Stimson E.R., Ghilardi J.R., Mantyh P.W., Lu Y.-A., Felix A.F., Llanos W., Behbin A., Cummings M., van Criekinge M., Timms W., Maggio J.E.et al. HNMR of Aβ amyloid peptide congeners in water solution. Conformational changes correlate with plaque competence. Biochemistry. 34:1995;5191-5200.
16. Levine H. III Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 2:1993;404-410.
17. Lomas D.A., Carrell R.W. Conformational disease. Lancet. 350:1997;134-138.
18. Lorenzo A., Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U.S.A. 91:1994;12243-12247.
19. Muller-Hill B., Beyreuter K. Molecular biology of Alzheimer's disease. Annu. Rev. Biochem. 58:1989;287-307.
20. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325.
21. Scott, J.K., 1992. Discovering peptide ligands using epitope libraries. Trends Biochem. Sci., 241-245.
22. Scott J.K., Smith G.P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
23. Selkoe D.J. The molecular pathology of Alzheimer disease. Neuron. 6:1991;487-498.
24. Silen J.L., Agard D.A. The x-lytic protease pro-region does not require a physical linkage to activate the protease domain in vivo. Nature. 341:1989;462.
25. Solomon B., Balas N. Thermostabilization of carboxypeptidase A by interaction with its monoclonal antibodies. Biotechnol. Appl. Biochem. 14:1991;202.
26. Solomon B., Schwartz F. Chaperone-like effect of monoclonal antibodies on refolding of heat-denatured carboxypeptidase A. J. Molec. Recogn. 8:1995;72.
27. Solomon B., Schmitt S., Schwartz F., Levi A., Fleminger G. Eupergit C-coated membranes as solid support for a sensitive immunoassay of human albumin. J. Immunol. Meth. 157:1993;209.
28. Solomon B., Koppel R., Hanan E., Katzav T. Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer β-amyloid peptide. Proc. Natl. Acad. Sci. U.S.A. 93:1996;452-455.
29. Solomon B., Koppel R., Frenkel D., Hanan-Aharon E. Disaggregation of Alzheimer β-amyloid by site-directed mAb. Proc. Natl. Acad. Sci. U.S.A. 94:1997;4109-4112.
30. Soto C., Castano E.M., Frangione B., Inestrosa N.C. The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 270:1995;3063-3067.
31. Strittmatter W.J., Burke J.R., DeSerrano V.S., Huang D.Y., Matthew W., Saunders A.M., Scott B.L., Vance J.M., Weisgraber K.H., Roses A.D. Protein-protein interactions in Alzheimer's disease and the CAG triplet repeat diseases. Cold Spring Harbor Symposia on Quantitative Biology. LXI:1996;597-605.